QIAGEN Reports Results for Fourth Quarter and Full-Year 2018

글 내용 전체보기

APhA Attends Swearing-In Ceremony of National Drug Control Policy Director

글 내용 전체보기

The Vitamin Shoppe® Announces New Senior Vice President, Retail Sales & Operations

글 내용 전체보기

VALBIOTIS Strengthens its Board of Directors with the Appointment of Murielle CAZAUBIEL

글 내용 전체보기

ArTara Therapeutics Announces Additions to Leadership Team and Board of Directors

글 내용 전체보기

GlobalMed Virtual Care Platform Now Available in the Microsoft Azure Marketplace

글 내용 전체보기

InventHelp Inventor Designs Innovative Assistive Device (MBC-181)

글 내용 전체보기

GORE™ ImproJectTM Plunger for Pre-Filled Syringes at Pharmapack Europe

글 내용 전체보기

Gestalt Diagnostics Expands Market Reach and Solution Offerings with Peak Medical Acquisition

글 내용 전체보기

Maxim Healthcare Services Names National Caregiver of the Year

글 내용 전체보기

You Are Getting Very Sleepy: Eisai and Purdue Pharma Release Phase III Data on Insomnia Drug

글 내용 전체보기

What’s New in the Biodefense Market These Days?

글 내용 전체보기

PhRMA and BIO Offer Support of HHS Rebate Proposal, While Insurers Balk at the Plan

글 내용 전체보기

GenSight’s LHON Gene Therapy Fails to Meet Endpoints at Week 48

글 내용 전체보기

Moderna’s Not the Only One: A Look at the mRNA Market

글 내용 전체보기

Lilly and Incyte’s Olumiant Hits the Mark in Two Phase III Atopic Dermatitis Trials

글 내용 전체보기

Argenx and Halozyme Ink Multiple Target Deal That Could Hit $540 Million

글 내용 전체보기

FDA Action Alert: Sanofi, Motif Bio and Merck

글 내용 전체보기

Germany’s Sirion Biotech Launches New U.S. Headquarters in Cambridge

글 내용 전체보기

FDA Rejects Alkermes’ Opioid Modulator Treatment for Depression

글 내용 전체보기

Why Isolated, Single-Analyte Biomarkers Lead to Failed Trials

글 내용 전체보기